Preclinical safety demonstration of the human recombinant erythropoietin HEBERITRO®

Article

Abstract: Erythropoietin (EPO) is a glycoprotein that appears in blood as a response to hypoxia, acting on bon

Palabras claves:

EPREX®, erythropoietin, Preclinical toxicology, safety

Autores:

Bacardí D.M., Cosme K., Gutiérrez A., I. Howland-Álvarez, Ivón Howland-Álvarez, Merino N., Pérez-Caballero M., Porras D.N., Suaréz J., Urquiza D., Vázquez A.

Fuentes:

google

scopus